371 related articles for article (PubMed ID: 33334821)
21. Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.
Zhu S; Chen Z; Katsha A; Hong J; Belkhiri A; El-Rifai W
Oncogene; 2016 Apr; 35(14):1847-56. PubMed ID: 26119931
[TBL] [Abstract][Full Text] [Related]
22. SR proteins regulate V6 exon splicing of CD44 pre-mRNA.
Loh TJ; Moon H; Jang HN; Liu Y; Choi N; Shen S; Williams DR; Jung DW; Zheng X; Shen H
BMB Rep; 2016 Nov; 49(11):612-616. PubMed ID: 27530682
[TBL] [Abstract][Full Text] [Related]
23. SR protein expression and CD44 splicing pattern in human breast tumours.
Pind MT; Watson PH
Breast Cancer Res Treat; 2003 May; 79(1):75-82. PubMed ID: 12779084
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.
Bánky B; Rásó-Barnett L; Barbai T; Tímár J; Becságh P; Rásó E
Mol Cancer; 2012 Nov; 11():83. PubMed ID: 23151220
[TBL] [Abstract][Full Text] [Related]
25. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
Roy Burman D; Das S; Das C; Bhattacharya R
Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
[TBL] [Abstract][Full Text] [Related]
26. Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition.
Reinke LM; Xu Y; Cheng C
J Biol Chem; 2012 Oct; 287(43):36435-42. PubMed ID: 22961986
[TBL] [Abstract][Full Text] [Related]
27. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA.
Loh TJ; Moon H; Cho S; Jung DW; Hong SE; Kim DH; Green MR; Zheng X; Zhou J; Shen H
Oncol Rep; 2014 Jan; 31(1):273-9. PubMed ID: 24173428
[TBL] [Abstract][Full Text] [Related]
28. U2-related proteins CHERP and SR140 contribute to colorectal tumorigenesis via alternative splicing regulation.
Wang Q; Wang Y; Liu Y; Zhang C; Luo Y; Guo R; Zhan Z; Wei N; Xie Z; Shen L; Wu G; Wu W; Feng Y
Int J Cancer; 2019 Nov; 145(10):2728-2739. PubMed ID: 30977118
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma.
Liu W; Li D; Lu T; Zhang H; Chen Z; Ruan Q; Zheng Z; Chen L; Guo J
J Biol Chem; 2023 Feb; 299(2):102876. PubMed ID: 36623729
[TBL] [Abstract][Full Text] [Related]
30. SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression.
Matsushita K; Kajiwara T; Tamura M; Satoh M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Yoshimoto R; Ito A; Kubo S; Natsume T; Levens D; Yoshida M; Nomura F
Mol Cancer Res; 2012 Jun; 10(6):787-99. PubMed ID: 22496461
[TBL] [Abstract][Full Text] [Related]
31. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
[TBL] [Abstract][Full Text] [Related]
32. Expression of CD44 Isoforms in Tumor Samples and Cell Lines of Human Colorectal Cancer.
Novosad VO; Polikanova IS; Tonevitsky EA; Maltseva DV
Bull Exp Biol Med; 2022 May; 173(1):155-159. PubMed ID: 35618971
[TBL] [Abstract][Full Text] [Related]
33. Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis.
Best SA; Vandenberg CJ; Abad E; Whitehead L; Guiu L; Ding S; Brennan MS; Strasser A; Herold MJ; Sutherland KD; Janic A
Cell Death Dis; 2020 Oct; 11(10):877. PubMed ID: 33082333
[TBL] [Abstract][Full Text] [Related]
34. Nuclear Speckle-related Protein 70 Binds to Serine/Arginine-rich Splicing Factors 1 and 2 via an Arginine/Serine-like Region and Counteracts Their Alternative Splicing Activity.
Kim CH; Kim YD; Choi EK; Kim HR; Na BR; Im SH; Jun CD
J Biol Chem; 2016 Mar; 291(12):6169-81. PubMed ID: 26797131
[TBL] [Abstract][Full Text] [Related]
35. YB-1 binds to CAUC motifs and stimulates exon inclusion by enhancing the recruitment of U2AF to weak polypyrimidine tracts.
Wei WJ; Mu SR; Heiner M; Fu X; Cao LJ; Gong XF; Bindereif A; Hui J
Nucleic Acids Res; 2012 Sep; 40(17):8622-36. PubMed ID: 22730292
[TBL] [Abstract][Full Text] [Related]
36. No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer.
Givehchian M; Wörner S; Sträter J; Zöller M; Heuschen U; Heuschen G; Lehnert T; Herfarth C; von Knebel Doeberitz M
Eur J Cancer; 1998 Jun; 34(7):1099-1104. PubMed ID: 9849461
[TBL] [Abstract][Full Text] [Related]
37. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells.
Bhattacharya R; Mitra T; Ray Chaudhuri S; Roy SS
J Cell Biochem; 2018 Apr; 119(4):3373-3383. PubMed ID: 29130517
[TBL] [Abstract][Full Text] [Related]
39. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
40. Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
Gaiteiro C; Soares J; Relvas-Santos M; Peixoto A; Ferreira D; Paulo P; Brandão A; Fernandes E; Azevedo R; Palmeira C; Freitas R; Miranda A; Osório H; Prieto J; Lima L; Silva AMN; Santos LL; Ferreira JA
Theranostics; 2022; 12(7):3150-3177. PubMed ID: 35547758
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
